Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine by Simon eZhornitsky, Emmanuel eStip, Joelle eDesfosses, Tania ePampoulova, Elie eRizkallah, Elie eRizkallah, Pierre-Paul eRompre, Lahcen Ait Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alain eGendron, Stephane ePotvin

Get full text